Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkad1196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Eeson Rajendra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Artios Pharma Ltd, Babraham Research Campus, Cambridge CB22 3FH, UK. Hauptthemen laut MEDLINE: DNA Repair, High-Throughput Screening Assays. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Artios Pharma Ltd, Francis Crick Institute.
Abstract (Originalsprache)
Repair of DNA damage is essential for the maintenance of genome stability and cell viability. DNA double strand breaks (DSBs) constitute a toxic class of DNA lesion and multiple cellular pathways exist to mediate their repair. Robust and titratable assays of cellular DSB repair (DSBR) are important to functionally interrogate the integrity and efficiency of these mechanisms in disease models as well as in response to genetic or pharmacological perturbations. Several variants of DSBR reporters are available, however these are often limited by throughput or restricted to specific cellular models. Here, we describe the generation and validation of a suite of extrachromosomal reporter assays that can efficiently measure the major DSBR pathways of homologous recombination (HR), classical nonhomologous end joining (cNHEJ), microhomology-mediated end joining (MMEJ) and single strand annealing (SSA). We demonstrate that these assays can be adapted to a high-throughput screening format and that they are sensitive to pharmacological modulation, thus providing mechanistic and quantitative insights into compound potency, selectivity, and on-target specificity. We propose that these reporter assays can serve as tools to dissect the interplay of DSBR pathway networks in cells and will have broad implications for studies of DSBR mechanisms in basic research and drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Artios Pharma Ltd, Babraham Research Campus, Cambridge CB22 3FH, UK.
- The Francis Crick Institute, London NW1 1AT, UK.
ORCID-Profile: Eeson Rajendra, Graeme Hewitt, Alessandro Galbiati
Förderung
- Wellcome Trust
- Artios Pharma Ltd
- Francis Crick Institute
- European Research Council Advanced Investigator
- CRUK RadNet City of London
Zitieren
APA
Rajendra, E., Grande, D., Mason, B., Di Marcantonio, D., Armstrong, L., Hewitt, G., Elinati, E., Galbiati, A., Boulton, S. J., Heald, R. A., Smith, G. C. M., & Robinson, H. M. R. (2024). Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1196
Vancouver
Rajendra E, Grande D, Mason B, Di Marcantonio D, Armstrong L, Hewitt G, et al. Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1196
BibTeX
@article{Rajendra2024,
author = {Rajendra, Eeson and Grande, Diego and Mason, Bethany and Di Marcantonio, Daniela and Armstrong, Lucy and Hewitt, Graeme and Elinati, Elias and Galbiati, Alessandro and Boulton, Simon J and Heald, Robert A and Smith, Graeme C M and Robinson, Helen M R},
title = {Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkad1196}
}
EUVIMED